Allergan's behavior here is unacceptable, and if other drug companies follow its lead, the problem is only going to get worse.
Maggie Hassan: “Allergan's behavior here is unacceptable, and if other drug companies follow its lead, the problem is only going to get…”
Editor's note · Context
Hassan criticizes Allergan's actions and warns of broader implications for drug pricing.
Share
More from Maggie Hassan
“I valued the opportunity to hear about the challenges that they face when it comes to hiring and retaining qualified teachers, even as demand for child care remains incredibly high.
Too often, victims of identity theft are forced to navigate a long, confusing process to get support from the Social Security Administration. This process is frustrating to victims and unnecessarily drains the agency’s resources.
Romance scams are devastating – both financially and emotionally – to people who are looking for connection and instead find themselves targeted and exploited by global criminal enterprises.
I am deeply concerned that disruptions to PRAMS have left permanent gaps in our understanding of maternal and infant health.





